Developer docs
API playgroundTry for free, no card

Search company profiles

Lanmer

Full company profile

uuid0033yjm

Namestring
Lanmer
Legal namestring
Lanmer OÜ
Websiteurl
lanmer.eu
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Lanmer OÜ, founded in 2014 in Tartu, Estonia by Merlin Langel, is a private B2B services and distribution company that operates three interconnected divisions under the Lanmer Group umbrella: Lanmer CRO, Lanmer Distro, and Lanmer Hardware Venture Studio (HVS) with its flagship Langel Labs innovation facility. Lanmer CRO delivers full-service clinical trial management, regulatory affairs support (EU CTR/CTIS, MDR, IVDR, CE-marking), medical writing, patient recruitment, and quality assurance across all EU member states, the Balkans, Türkiye, the Middle East, and Africa, operating through a senior network of regional specialists rather than full-time employees in each geography. Lanmer Distro distributes laboratory and medical equipment, consumables, and instruments from global manufacturers including Thermo Fisher Scientific, Benchmark Scientific, and Singer Instruments to research laboratories, healthcare institutions, and manufacturers in the Baltic and Nordic regions, supplemented by installation, maintenance, repair, training, lab design, and compliance consulting services.

Lanmer's core technology footprint is largely distributional rather than proprietary — the company does not develop laboratory instruments or software platforms. Its principal internally built assets are Langel Labs, a purpose-built R&D infrastructure supporting molecular biology, nanomaterial research, nanoformulation, and biospecimen analysis, and an integrated multi-division ecosystem that connects clinical operations, equipment distribution, and deep-tech venture support under a single corporate brand. The company generates revenue through three streams: hardware sales and lifecycle services (Distro), professional services contracts for clinical research (CRO), and consulting/advisory fees plus investment facilitation for hardware and biotech ventures (HVS). Pricing is not publicly disclosed; all engagements are consultation-driven, with quotes tailored to project scope. Target customers are enterprise clients — pharmaceutical and biotechnology sponsors, medical device and diagnostic developers, research laboratories, healthcare institutions, and deep-tech startups in the Baltic, Nordic, and broader European/CIS-adjacent regions. The company holds ISO 9001:2015 certification covering its equipment sales, consultation, installation, maintenance, and repair activities.

The business is led by a small core team (1–10 employees per firmographic data), anchored by CEO Merlin Langel (17+ years of clinical research and regulatory experience across ICON plc, Optimapharm, Comac Medical, and Crown CRO) and Senior Advisor Päivi Itkonen (30+ years, former Director of Clinical Research for Nordics and Baltics at Quintiles and founder/CEO of Crown CRO Oy prior to its acquisition by Optimapharm). No external funding rounds, institutional investors, or revenue figures are disclosed in the available materials.

Short descriptiontext

Lanmer OÜ is a Tartu, Estonia-based B2B services company operating three divisions: Lanmer CRO (clinical research and regulatory affairs across Europe and emerging markets), Lanmer Distro (laboratory and medical equipment distribution in the Baltics and Nordics), and Lanmer Hardware Venture Studio (deep-tech innovation support via its Langel Labs facility), serving pharma, biotech, medical device, and research clients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTartu, Estonia
HQ citystring
Tartu
HQ countrystring
Estonia
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, laboratory equipment distribution, medical device distribution, regulatory affairs consulting, deep tech venture studio
Industry3 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
NAICS code3 codes
  • Management Consulting Services54161
  • Other Scientific and Technical Consulting Services54169
  • Other Scientific and Technical Consulting Services541690
SIC code3 codes
  • Services-Medical Laboratories8071
  • Wholesale-Hardware5072
  • Services-Management Consulting Services8742
Product category
Laboratory Equipment Distribution & Clinical Research Services
No data
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Laboratory & Medical Equipment Distribution
TypeHardware Sales
Description

Lanmer Distro distributes cutting-edge laboratory equipment, medical devices, and consumables from world-leading manufacturers like Thermo Fisher Scientific. Revenue is generated through product sales, consultation services, installation, maintenance, and repair services. The company has established partnerships with leading global manufacturers to bring high-quality technologies to the Baltic and Nordic regions.

lanmer.eu
2Clinical Research Services
TypeProfessional Services
Description

Lanmer CRO provides full-service clinical research operations including clinical trial management, regulatory submissions, medical writing, patient recruitment, site monitoring, and quality assurance. Services span from EU CTR/CTIS regulated studies to non-CTIS territories. Revenue generated through project-based professional services contracts with pharmaceutical, biotechnology, and medical device sponsors.

lanmer.eu
3Hardware Venture Studio Advisory & Consulting
TypeProfessional Services
Description

Lanmer HVS provides advisory services for deep-tech and hardware development including project planning for advanced facilities, business development, go-to-market strategies, manufacturing scale-up consulting, medical device regulatory compliance (EU MDR, IVDR, CE-marking), and public/private investment facilitation. Revenue generated through consulting fees and partnership arrangements.

lanmer.eu
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1Lanmer CRO
Description

Clinical Research and Regulatory Operations - European full-service CRO providing clinical trial management, regulatory support, and operations across Europe, Balkans, Türkiye, and Africa.

lanmer.eu
+3 more records
Core offering1 text field

Lanmer Group is a multidisciplinary B2B organization operating three interconnected divisions: Lanmer CRO provides full-service clinical trial management, regulatory affairs, medical writing, patient recruitment, and quality assurance across Europe and emerging regions; Lanmer Distro distributes laboratory and medical equipment, consumables, and related installation, maintenance, and consultation services from global manufacturers such as Thermo Fisher Scientific; Lanmer Hardware Venture Studio delivers advisory, regulatory compliance (EU MDR/IVDR), go-to-market strategy, and investment facilitation for deep-tech startups, anchored by the Langel Labs R&D infrastructure.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Reduced development cycles and accelerated time-to-market through tailored project management and commercialization strategy
+2 more records
Product overview1 text field

Lanmer Group is a multidisciplinary organization comprising three interconnected divisions: Lanmer CRO (Clinical Research Organization providing full-service clinical trial management and regulatory support across Europe and emerging regions), Lanmer Distro (medical and laboratory equipment distribution with consultation services covering laboratory supplies, medical research tools, manufacturing equipment, and installation/maintenance services), and Lanmer Hardware Venture Studio (supporting deep-tech and hardware development with advisory, infrastructure access, and investment facilitation through its Langel Labs innovation laboratory). The company operates as a portfolio of specialized sub-brands offering consultation-driven solutions rather than a unified software platform.

Product and service4 records
1Lanmer CRO
CategoryClinical Research Organization Services
Description

Full-service Clinical Research Organization providing clinical trial management, regulatory affairs, medical writing, patient recruitment, site monitoring, and quality assurance for pharmaceutical, biotechnology, and medical-device sponsors across all EU member states, the Balkans, Türkiye, Middle East, and Africa.

2Lanmer Distro
CategoryLaboratory & Medical Equipment Distribution
Description

Distribution and consultation division supplying medical and laboratory equipment, consumables, and lab infrastructure to research laboratories and healthcare institutions across the Baltic and Nordic regions, with installation, maintenance, repair, and warranty services. Partners with Thermo Fisher Scientific and other global manufacturers.

3Lanmer Hardware Venture Studio (HVS)
CategoryDeep-Tech Venture Studio & Advisory Services
Description

Advisory and venture studio platform supporting deep-tech and hardware development through project planning for advanced facilities, business development, go-to-market strategy, manufacturing scale-up consulting, medical device regulatory compliance (EU MDR, IVDR, CE-marking), investment facilitation, and custom innovation programs.

4Langel Labs
CategoryInnovation Laboratory & R&D Infrastructure
Description

Innovation laboratory and flagship initiative of Lanmer Hardware Venture Studio providing modern R&D infrastructure, analytical capabilities, and expert collaboration for startups, research institutions, and industrial partners across molecular biology, nanomaterial research, nanoformulation, and biospecimen analysis.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Thermo Fisher Scientific is listed as an Industry & Corporate Partner. Lanmer Distro distributes Thermo Fisher Scientific products including laboratory equipment, instruments, and consumables across the Baltic and Nordic regions. The partnership provides access to comprehensive portfolio of laboratory solutions for research, diagnostics, and manufacturing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Tehnopol, a Public & Innovation Programs partner, collaborates with Lanmer on innovation ecosystem development and startup support programs in Estonia. Tehnopol is a prominent innovation hub supporting technology ventures and research commercialization.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

University of Tartu is listed as an Academic & Research Institution partner. The partnership provides collaboration opportunities for technology translation, joint research, and access to academic expertise in the biotechnology and life sciences sectors.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

TalTech (Tallinn University of Technology) is listed as an Academic & Research Institution partner, providing potential collaboration on research projects, technology development, and talent access for deep-tech innovation initiatives.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

QPS is listed as a Clinical & Regulatory Partner. QPS is a global contract research organization specializing in preclinical and clinical trial services, enabling collaboration on clinical research operations and regulatory affairs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Tartu Biotechnology Park is an Academic & Research Institution partner that strengthens Lanmer's position in the Baltic biotechnology ecosystem and provides access to regional research infrastructure and expertise.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Horizon Europe is listed as a partnership for Regional and EU Project Participation, enabling Lanmer HVS to engage in collaborative research and innovation projects funded by the European Union's research and innovation program.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

Enterprise Estonia supports Lanmer through national innovation programs and business development initiatives, providing access to funding opportunities and regional innovation ecosystem resources.

Strategic tierSecondaryTypeChannel Partner/ Reseller/ Distributor
Description

Singer Instruments is listed as a partner, with Lanmer distributing their products including specialized instruments for synthetic biology and laboratory applications.

10TBD Pharmatech
Strategic tierMinorTypeStrategic or Co-development Partner
Description

TBD Pharmatech is listed as a partner, representing potential collaboration in pharmaceutical technology development and commercialization.

lanmer.eu
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Icosagen is listed as a partner, providing potential collaboration opportunities in biotechnology research and development services.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

GSD Diagnostics is listed as a partner, representing potential distribution or collaboration in diagnostic solutions and testing technologies.

13Estonian Genome Centre
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Estonian Genome Centre is listed as an Academic & Research Institution partner, providing potential collaboration on genetic research and genomic data projects.

lanmer.eu
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeBroad incumbent
Description

Largest global CRO and life-science technology provider (former Quintiles); Senior Advisor Päivi Itkonen previously led clinical research for Nordics and Baltics at Quintiles, making it the dominant incumbent against which Lanmer CRO is benchmarked.

TypeBroad incumbent
Description

Global distributor of laboratory supplies and equipment (including the VWR brand), competing directly with Lanmer Distro at the manufacturer-distribution interface, particularly for lab consumables and instruments in Europe.

TypeBroad incumbent
Description

Global leader in bioanalytical and clinical laboratory testing services with deep European footprint; comparable to Lanmer's positioning at the intersection of lab services, equipment and clinical research support.

TypeBroad incumbent
Description

Mid-to-large global CRO focused on Phase II–III trials with growing European operations, competing for the same biotech and mid-pharma sponsors as Lanmer CRO.

TypeDirect peer
Description

Mid-sized CRO specializing in Central and Eastern Europe with comparable Phase I–IV clinical trial and regulatory services; also a former employer of Lanmer's CEO, making it a closely comparable regional peer.

TypeBroad incumbent
Description

World-leading manufacturer whose products Lanmer Distro distributes and which can sell direct or through competing channel partners; the strategic principal whose channel decisions materially shape Lanmer's distribution opportunity.

TypeBroad incumbent
Description

Global CRO with strong discovery, safety assessment and clinical operations; competing for the same biotech and pharma sponsors targeting European clinical programs that Lanmer CRO pursues.

8BioNordika
TypeDirect peer
Description

Nordics- and Baltics-focused distributor of life science reagents, instruments and consumables — the closest regional functional analogue to Lanmer Distro, with overlapping manufacturer relationships and customer base in research and clinical labs.

TypeBroad incumbent
Description

Global top-3 CRO offering Phase I–IV clinical trial management and regulatory services; a former employer of Lanmer's founder and the dominant scale competitor whose strategic moves (e.g., PRA acquisition) shape the addressable market.

10Optimapharm
TypeDirect peer
Description

European full-service CRO with a strong CEE and Nordics footprint and direct overlap with Lanmer CRO; Optimapharm is also a former employer of CEO Merlin Langel and acquired Crown CRO (founded by Lanmer advisor Päivi Itkonen).

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lanmer

Laboratory Equipment Distribution & Clinical Research Serviceslanmer.eu

Lanmer OÜ is a Tartu, Estonia-based B2B services company operating three divisions: Lanmer CRO (clinical research and regulatory affairs across Europe and emerging markets), Lanmer Distro (laboratory and medical equipment distribution in the Baltics and Nordics), and Lanmer Hardware Venture Studio (deep-tech innovation support via its Langel Labs facility), serving pharma, biotech, medical device, and research clients.

What Lanmer does

Lanmer OÜ, founded in 2014 in Tartu, Estonia by Merlin Langel, is a private B2B services and distribution company that operates three interconnected divisions under the Lanmer Group umbrella: Lanmer CRO, Lanmer Distro, and Lanmer Hardware Venture Studio (HVS) with its flagship Langel Labs innovation facility. Lanmer CRO delivers full-service clinical trial management, regulatory affairs support (EU CTR/CTIS, MDR, IVDR, CE-marking), medical writing, patient recruitment, and quality assurance across all EU member states, the Balkans, Türkiye, the Middle East, and Africa, operating through a senior network of regional specialists rather than full-time employees in each geography. Lanmer Distro distributes laboratory and medical equipment, consumables, and instruments from global manufacturers including Thermo Fisher Scientific, Benchmark Scientific, and Singer Instruments to research laboratories, healthcare institutions, and manufacturers in the Baltic and Nordic regions, supplemented by installation, maintenance, repair, training, lab design, and compliance consulting services.

Lanmer's core technology footprint is largely distributional rather than proprietary — the company does not develop laboratory instruments or software platforms. Its principal internally built assets are Langel Labs, a purpose-built R&D infrastructure supporting molecular biology, nanomaterial research, nanoformulation, and biospecimen analysis, and an integrated multi-division ecosystem that connects clinical operations, equipment distribution, and deep-tech venture support under a single corporate brand. The company generates revenue through three streams: hardware sales and lifecycle services (Distro), professional services contracts for clinical research (CRO), and consulting/advisory fees plus investment facilitation for hardware and biotech ventures (HVS). Pricing is not publicly disclosed; all engagements are consultation-driven, with quotes tailored to project scope. Target customers are enterprise clients — pharmaceutical and biotechnology sponsors, medical device and diagnostic developers, research laboratories, healthcare institutions, and deep-tech startups in the Baltic, Nordic, and broader European/CIS-adjacent regions. The company holds ISO 9001:2015 certification covering its equipment sales, consultation, installation, maintenance, and repair activities.

The business is led by a small core team (1–10 employees per firmographic data), anchored by CEO Merlin Langel (17+ years of clinical research and regulatory experience across ICON plc, Optimapharm, Comac Medical, and Crown CRO) and Senior Advisor Päivi Itkonen (30+ years, former Director of Clinical Research for Nordics and Baltics at Quintiles and founder/CEO of Crown CRO Oy prior to its acquisition by Optimapharm). No external funding rounds, institutional investors, or revenue figures are disclosed in the available materials.

Lanmer firmographics

Firmographics
Name
Lanmer
Legal name
Lanmer OÜ
Website
https://lanmer.eu
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
Lanmer OÜ is a Tartu, Estonia-based B2B services company operating three divisions: Lanmer CRO (clinical research and regulatory affairs across Europe and emerging markets), Lanmer Distro (laboratory and medical equipment distribution in the Baltics and Nordics), and Lanmer Hardware Venture Studio (deep-tech innovation support via its Langel Labs facility), serving pharma, biotech, medical device, and research clients.
Ownership category
akta.pro rank

Lanmer industry classification

Industry
Product category
Laboratory Equipment Distribution & Clinical Research Services
NAICS
Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169), Other Scientific and Technical Consulting Services (541690)
SIC
Services-Medical Laboratories (8071), Wholesale-Hardware (5072), Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs

Keywords

  • Clinical research services
  • Laboratory equipment distribution
  • Medical device distribution
  • Regulatory affairs consulting
  • Deep tech venture studio

Where Lanmer is headquartered

Location

Headquarters

HQ city
Tartu
HQ country
Estonia
HQ region
Europe

Offices1 record

Markets served

Lanmer business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

  1. Laboratory & Medical Equipment Distribution: Lanmer Distro distributes cutting-edge laboratory equipment, medical devices, and consumables from world-leading manufacturers like Thermo Fisher Scientific. Revenue is generated through product sales, consultation services, installation, maintenance, and repair services. The company has established partnerships with leading global manufacturers to bring high-quality technologies to the Baltic and Nordic regions.
  2. Clinical Research Services: Lanmer CRO provides full-service clinical research operations including clinical trial management, regulatory submissions, medical writing, patient recruitment, site monitoring, and quality assurance. Services span from EU CTR/CTIS regulated studies to non-CTIS territories. Revenue generated through project-based professional services contracts with pharmaceutical, biotechnology, and medical device sponsors.
  3. Hardware Venture Studio Advisory & Consulting: Lanmer HVS provides advisory services for deep-tech and hardware development including project planning for advanced facilities, business development, go-to-market strategies, manufacturing scale-up consulting, medical device regulatory compliance (EU MDR, IVDR, CE-marking), and public/private investment facilitation. Revenue generated through consulting fees and partnership arrangements.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Lanmer product offering

Product offering

Core offering

Lanmer Group is a multidisciplinary B2B organization operating three interconnected divisions: Lanmer CRO provides full-service clinical trial management, regulatory affairs, medical writing, patient recruitment, and quality assurance across Europe and emerging regions; Lanmer Distro distributes laboratory and medical equipment, consumables, and related installation, maintenance, and consultation services from global manufacturers such as Thermo Fisher Scientific; Lanmer Hardware Venture Studio delivers advisory, regulatory compliance (EU MDR/IVDR), go-to-market strategy, and investment facilitation for deep-tech startups, anchored by the Langel Labs R&D infrastructure.

Product overview

Lanmer Group is a multidisciplinary organization comprising three interconnected divisions: Lanmer CRO (Clinical Research Organization providing full-service clinical trial management and regulatory support across Europe and emerging regions), Lanmer Distro (medical and laboratory equipment distribution with consultation services covering laboratory supplies, medical research tools, manufacturing equipment, and installation/maintenance services), and Lanmer Hardware Venture Studio (supporting deep-tech and hardware development with advisory, infrastructure access, and investment facilitation through its Langel Labs innovation laboratory). The company operates as a portfolio of specialized sub-brands offering consultation-driven solutions rather than a unified software platform.

Differentiator

Problem solved

Functional benefit

Brands

  • Lanmer CRO: Clinical Research and Regulatory Operations - European full-service CRO providing clinical trial management, regulatory support, and operations across Europe, Balkans, Türkiye, and Africa.
  • Lanmer Distro
  • Lanmer Hardware Venture Studio (HVS)
  • Langel Labs

Products and services

  • Lanmer CRO Full-service Clinical Research Organization providing clinical trial management, regulatory affairs, medical writing, patient recruitment, site monitoring, and quality assurance for pharmaceutical, biotechnology, and medical-device sponsors across all EU member states, the Balkans, Türkiye, Middle East, and Africa.
  • Lanmer Distro Distribution and consultation division supplying medical and laboratory equipment, consumables, and lab infrastructure to research laboratories and healthcare institutions across the Baltic and Nordic regions, with installation, maintenance, repair, and warranty services. Partners with Thermo Fisher Scientific and other global manufacturers.
  • Lanmer Hardware Venture Studio (HVS) Advisory and venture studio platform supporting deep-tech and hardware development through project planning for advanced facilities, business development, go-to-market strategy, manufacturing scale-up consulting, medical device regulatory compliance (EU MDR, IVDR, CE-marking), investment facilitation, and custom innovation programs.
  • Langel Labs Innovation laboratory and flagship initiative of Lanmer Hardware Venture Studio providing modern R&D infrastructure, analytical capabilities, and expert collaboration for startups, research institutions, and industrial partners across molecular biology, nanomaterial research, nanoformulation, and biospecimen analysis.

Quantifiable outcome

  • Reduced development cycles and accelerated time-to-market through tailored project management and commercialization strategy
  • +2 more outcomes

Companies that use Lanmer

Customer profile

Segments4 records

Ideal customer profiles4 records

Lanmer technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Lanmer partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core, secondary and minor.

  • Thermo Fisher ScientificcoreChannel Partner/ Reseller/ DistributorThermo Fisher Scientific is listed as an Industry & Corporate Partner. Lanmer Distro distributes Thermo Fisher Scientific products including laboratory equipment, instruments, and consumables across the Baltic and Nordic regions. The partnership provides access to comprehensive portfolio of laboratory solutions for research, diagnostics, and manufacturing.
  • TehnopolcoreStrategic or Co-development PartnerTehnopol, a Public & Innovation Programs partner, collaborates with Lanmer on innovation ecosystem development and startup support programs in Estonia. Tehnopol is a prominent innovation hub supporting technology ventures and research commercialization.
  • University of TartucoreStrategic or Co-development PartnerUniversity of Tartu is listed as an Academic & Research Institution partner. The partnership provides collaboration opportunities for technology translation, joint research, and access to academic expertise in the biotechnology and life sciences sectors.
  • TalTechsecondaryStrategic or Co-development PartnerTalTech (Tallinn University of Technology) is listed as an Academic & Research Institution partner, providing potential collaboration on research projects, technology development, and talent access for deep-tech innovation initiatives.
  • QPScoreStrategic or Co-development PartnerQPS is listed as a Clinical & Regulatory Partner. QPS is a global contract research organization specializing in preclinical and clinical trial services, enabling collaboration on clinical research operations and regulatory affairs.
  • Tartu Biotechnology ParkcoreStrategic or Co-development PartnerTartu Biotechnology Park is an Academic & Research Institution partner that strengthens Lanmer's position in the Baltic biotechnology ecosystem and provides access to regional research infrastructure and expertise.
  • Horizon EuropecoreStrategic or Co-development PartnerHorizon Europe is listed as a partnership for Regional and EU Project Participation, enabling Lanmer HVS to engage in collaborative research and innovation projects funded by the European Union's research and innovation program.
  • Enterprise Estonia (EIS)secondaryStrategic or Co-development PartnerEnterprise Estonia supports Lanmer through national innovation programs and business development initiatives, providing access to funding opportunities and regional innovation ecosystem resources.
  • Singer InstrumentssecondaryChannel Partner/ Reseller/ DistributorSinger Instruments is listed as a partner, with Lanmer distributing their products including specialized instruments for synthetic biology and laboratory applications.
  • TBD PharmatechminorStrategic or Co-development PartnerTBD Pharmatech is listed as a partner, representing potential collaboration in pharmaceutical technology development and commercialization.
  • IcosagenminorStrategic or Co-development PartnerIcosagen is listed as a partner, providing potential collaboration opportunities in biotechnology research and development services.
  • GSD DiagnosticsminorChannel Partner/ Reseller/ DistributorGSD Diagnostics is listed as a partner, representing potential distribution or collaboration in diagnostic solutions and testing technologies.
  • Estonian Genome CentreminorStrategic or Co-development PartnerEstonian Genome Centre is listed as an Academic & Research Institution partner, providing potential collaboration on genetic research and genomic data projects.

Scale indicators4 records

Recent moves3 records

Lanmer competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: Largest global CRO and life-science technology provider (former Quintiles); Senior Advisor Päivi Itkonen previously led clinical research for Nordics and Baltics at Quintiles, making it the dominant incumbent against which Lanmer CRO is benchmarked.
  • Avantor: Global distributor of laboratory supplies and equipment (including the VWR brand), competing directly with Lanmer Distro at the manufacturer-distribution interface, particularly for lab consumables and instruments in Europe.
  • Eurofins Scientific: Global leader in bioanalytical and clinical laboratory testing services with deep European footprint; comparable to Lanmer's positioning at the intersection of lab services, equipment and clinical research support.
  • Medpace: Mid-to-large global CRO focused on Phase II–III trials with growing European operations, competing for the same biotech and mid-pharma sponsors as Lanmer CRO.
  • Thermo Fisher Scientific (Laboratory Products & Services): World-leading manufacturer whose products Lanmer Distro distributes and which can sell direct or through competing channel partners; the strategic principal whose channel decisions materially shape Lanmer's distribution opportunity.
  • Charles River Laboratories: Global CRO with strong discovery, safety assessment and clinical operations; competing for the same biotech and pharma sponsors targeting European clinical programs that Lanmer CRO pursues.
  • ICON plc: Global top-3 CRO offering Phase I–IV clinical trial management and regulatory services; a former employer of Lanmer's founder and the dominant scale competitor whose strategic moves (e.g., PRA acquisition) shape the addressable market.

Direct peers

  • Comac Medical: Mid-sized CRO specializing in Central and Eastern Europe with comparable Phase I–IV clinical trial and regulatory services; also a former employer of Lanmer's CEO, making it a closely comparable regional peer.
  • BioNordika: Nordics- and Baltics-focused distributor of life science reagents, instruments and consumables — the closest regional functional analogue to Lanmer Distro, with overlapping manufacturer relationships and customer base in research and clinical labs.
  • Optimapharm: European full-service CRO with a strong CEE and Nordics footprint and direct overlap with Lanmer CRO; Optimapharm is also a former employer of CEO Merlin Langel and acquired Crown CRO (founded by Lanmer advisor Päivi Itkonen).

Market position

Strengths4 records

Weaknesses4 records

Key risks5 records

Key highlights6 records

Customer concentration

Lanmer compliance and trust

Trust signal

Compliance1 record

Lanmer financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lanmer leadership team

Management profile

Number of profiles

Profiles3 records

Lanmer subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Lanmer funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lanmer M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lanmer

What does Lanmer do?

Lanmer Group is a multidisciplinary B2B organization operating three interconnected divisions: Lanmer CRO provides full-service clinical trial management, regulatory affairs, medical writing, patient recruitment, and quality assurance across Europe and emerging regions; Lanmer Distro distributes laboratory and medical equipment, consumables, and related installation, maintenance, and consultation services from global manufacturers such as Thermo Fisher Scientific; Lanmer Hardware Venture Studio delivers advisory, regulatory compliance (EU MDR/IVDR), go-to-market strategy, and investment facilitation for deep-tech startups, anchored by the Langel Labs R&D infrastructure.

Is Lanmer a public or private company?

Lanmer is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Lanmer founded?

Lanmer was founded in 2014. It employs 11 to 50 people.

Where is Lanmer based?

Lanmer is headquartered in Tartu, Estonia, in the Europe region.

How does Lanmer make money?

Three revenue lines are on record. Laboratory & Medical Equipment Distribution is the primary driver. The others are clinical Research Services and hardware Venture Studio Advisory & Consulting.

Who are Lanmer's main competitors?

Broad incumbents on record are IQVIA, Avantor, Eurofins Scientific, Medpace, Thermo Fisher Scientific (Laboratory Products & Services), Charles River Laboratories and ICON plc. Direct peers are Comac Medical, BioNordika and Optimapharm.

Does Lanmer have an API?

No public API is recorded for Lanmer.

What industry is Lanmer in?

Lanmer's product category is Laboratory Equipment Distribution & Clinical Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 54161 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales